Active Implantable Medical Devices Market 2019 Global Analysis On Industry Development By Abbott, Cochlear, Boston Scientific, BIOTRONIK, MED-EL, Medtronic And Other, Research Report Forecast 2027

Active Implantable Medical Devices Market to 2025 - Global Analysis and Forecasts By Product (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, and Implantable Hearing Devices), End-User (Hospitals, Ambulatory Surgery Centers, and Specialty Clinics) and Geography

Active Implantable Medical Devices Market Research Report will assist you to take thoughtful decisions about market by explaining what the market Segments, demand, classifications, applications, engagements and Growth are and informing you about all the recent changes in Market, product launches & their researches, their merges, accusations, and joint ventures, and also explaining about all the scope and regional framework which are collected using SWOT analysis.

Global Active Implantable Medical Devices Market accounted to US$ 39,026.9 Mn in 2017 and is expected to grow at a CAGR of 7.9% during the forecast period 2018 – 2025, to account to US$ 22,096.9 Mn by 2025.

Get Sample PDF Of [email protected]

According to a new market research study titled ‘Active Implantable Medical Devices Market to 2025 – Global Analysis and Forecasts by Product and End User, the global active implantable medical devices market was valued at US$ 22,096.9 Mn in 2017 and is estimated to reach US$ 39,026.9 Mn by 2025. The market is estimated to grow with a CAGR of 7.9% from 2018-2025. The report highlights the trends prevalent in the global active implantable medical devices market and the factors driving the market along with those that act as deterrents to its growth.

Leading Key Players In Market:

  • Medtronic,
  • Abbott,
  • Boston Scientific Corporation,
  • LivaNova PLC,
  • Cochlear Ltd.,
  • MED-EL, Sonova,
  • William Demant Holding A/S,
  • Nurotron Biotechnology Co., Ltd

Comparative Analysis:

This Report also includes the profiles of others key Active Implantable Medical Devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Industry Strategic Insights :

Approvals and agreements were observed as the most adopted strategy in global active implantable medical devices industry. Few of the recent product launch and collaboration and others are listed below;

2018: In August, 2018, Abbott received FDA approval for software upgrade for its Infinity implants used to treat Parkinson’s and essential tremor full-body MRI compatibility.

2017: In November, 2017, Medtronic received CE (Conformité Européenne) Mark for the world’s smallest fully implantable spinal cord stimulator. The neurostimulator is placed under patient’s skin in order to deliver mild electrical impulses through a lead implanted in the epidural space, which act to block pain signals from going to the brain.

2016: In November 2016, BIOTRONIK today announced the launch of Inventra HF-T, implantable cardioverter defibrillator (ICD) that delivers an ultra-high energy with 42 joules (J) on the first shock. Thus providing technologically advanced products that improve patient lives.

Get More Analysis about Research [email protected]

Global Market Segments:

By Product

  • Implantable Cardioverter Defibrillators
    • Transvenous Implantable Cardioverter Defibrillators
    • Subcutaneous Implantable Cardioverter Defibrillators
  • Implantable Cardiac Pacemakers
  • Neurostimulators
  • Implantable Hearing Devices
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Speciality Clinics

By Geography

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • South America (SAM)

End User Insights:

The active implantale medical devices market by end user is segmented into hospitals, ambulatory surgery centers and specialty clinics. The hospitals segment is anticipated to grow at a CAGR of 8.1% during the forecast period. The increasing adoption of new technology devices in the hospitals and rising hospital research drives the market growth.

Click For More Discount [email protected]

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us:

The Insight partners,

Phone: +1-646-491-9876

Email: [email protected]


Related Articles